These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30306402)
1. Novel Random Triblock Copolymers for Sustained Delivery of Macromolecules for the Treatment of Ocular Diseases. Ngatuni MJ; Trinh HM; Pal D; Mitra AK AAPS PharmSciTech; 2018 Nov; 19(8):3871-3885. PubMed ID: 30306402 [TBL] [Abstract][Full Text] [Related]
3. Novel pentablock copolymer-based nanoparticulate systems for sustained protein delivery. Patel SP; Vaishya R; Pal D; Mitra AK AAPS PharmSciTech; 2015 Apr; 16(2):327-43. PubMed ID: 25319053 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases. Agrahari V; Patel SP; Dhall N; Aulgur Z; Thukral S; Yang X; Conley R; Mitra AK Drug Deliv Transl Res; 2018 Apr; 8(2):422-435. PubMed ID: 29181835 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate. Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051 [TBL] [Abstract][Full Text] [Related]
6. Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases. Patel SP; Vaishya R; Patel A; Agrahari V; Pal D; Mitra AK J Microencapsul; 2016; 33(2):103-13. PubMed ID: 26964498 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier. Pontillo ARN; Detsi A Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers. Yang Y; Hua C; Dong CM Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of in vitro insulin release from nanoparticles assembled by polyethylene glycol, polycaprolactone and polyethyleneimine]. Wang Y; Li W; Shen M; Chen Q; Zeng Q Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):109-15. PubMed ID: 26806749 [TBL] [Abstract][Full Text] [Related]
11. Investigation of cationized triblock and diblock poly(ε-caprolactone)-co-poly(ethylene glycol) copolymers for oral delivery of enoxaparin: In vitro approach. Charoongchit P; Suksiriworapong J; Mao S; Sapin-Minet A; Maincent P; Junyaprasert VB Acta Biomater; 2017 Oct; 61():180-192. PubMed ID: 28782723 [TBL] [Abstract][Full Text] [Related]
12. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin. Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238 [TBL] [Abstract][Full Text] [Related]
13. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting. Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461 [TBL] [Abstract][Full Text] [Related]
14. Tailor-made pentablock copolymer based formulation for sustained ocular delivery of protein therapeutics. Patel SP; Vaishya R; Mishra GP; Tamboli V; Pal D; Mitra AK J Drug Deliv; 2014; 2014():401747. PubMed ID: 25045540 [TBL] [Abstract][Full Text] [Related]
15. Triblock copolymers: synthesis, characterization, and delivery of a model protein. Chen S; Pieper R; Webster DC; Singh J Int J Pharm; 2005 Jan; 288(2):207-18. PubMed ID: 15620860 [TBL] [Abstract][Full Text] [Related]
16. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Mahmoud AA; El-Feky GS; Kamel R; Awad GE Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride. Ahmed OA; Zidan AS; Khayat M Int J Nanomedicine; 2016; 11():543-55. PubMed ID: 26893561 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation. Khalil IA; Ali IH; El-Sherbiny IM Nanomedicine (Lond); 2019 Jan; 14(1):33-55. PubMed ID: 30543484 [TBL] [Abstract][Full Text] [Related]
19. Sustained-release ketamine-loaded nanoparticles fabricated by sequential nanoprecipitation. Han FY; Liu Y; Kumar V; Xu W; Yang G; Zhao CX; Woodruff TM; Whittaker AK; Smith MT Int J Pharm; 2020 May; 581():119291. PubMed ID: 32259638 [TBL] [Abstract][Full Text] [Related]
20. Preparation, drug release and cellular uptake of doxorubicin-loaded dextran-b-poly(ɛ-caprolactone) nanoparticles. Li B; Wang Q; Wang X; Wang C; Jiang X Carbohydr Polym; 2013 Apr; 93(2):430-7. PubMed ID: 23499079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]